Medical and Pharmaceutical

Mugglehead speaks with MediPharm president Keith Strachan about how the cannabis extraction pioneer is gearing up for the launch of Cannabis 2.0 products in Canada.

A recent American Society of Anesthesiologists survey shows an escalating interest in marijuana for managing pain among U.S. adults, but the ASA warns more research is needed.

The former New England Patriots tight end will promote CBD products for Rhode Island-based Abacus Health while calling on the NFL to allow athletes to use the touted wellness extract.

Analysts have been bullish on the U.K. drugmaker raising estimates and price targets after its second-quarter sales easily surpassed expectations.

The initiative will allow Oregon customers to purchase a Curaleaf custom-designed pre-roll product, with a portion of all proceeds benefiting the Veterans Cannabis Project.

Louisiana joins more than 30 U.S. states, and the first one in the Deep South, with a medical cannabis program that officially began on Aug. 6 after a four-year regulatory hurdle.

Tiny Luxembourg could have a big effect on cannabis legalization in the European Union and open up the market for pot once the country goes recreational in two years.

A Tel Aviv-based team at Weedley is launching several clinical studies to test if CBD is an effective and safe way to treat pain in dogs and horses.

The Edmonton-based pot producer will supply 400 kilograms of medical cannabis to Italy under the contract, but securing the bid at $2.54 per gram may actually hurt Aurora's bottom line.

Researchers found the number of U.S. high school students who said they used pot at least once a month jumped from 0.6 per cent in 1991 to 6.3 per cent in 2017.

One-in-four medical cannabis users said supply issues have been preventing them from getting the medicine they need, according to a survey commissioned by Canadian Pharmacists Association and two other groups.

Gov. Phil Murphy signed the Jake Honig Compassionate Use Medical Cannabis Act on Tuesday, to make cannabis more accessible for patients battling disease and needing pain relief.

Ireland's Health Minister signed legislation last week which will allow citizens to gain limited access to medical cannabis to treat multiple sclerosis, chemotherapy-related illness and epilepsy.

It took eight years and $83 million dollars for Tel Aviv-based Syqe Medical to develop the new product that will allow medical marijuana patients to take accurate doses.

Toronto-based CannaHorse announced Wednesday it launched the world's first-ever legal cannabis brand dedicated to horse health.

Next fall, the University of Maryland School of Pharmacy will offer a two-year master's program designed for health care practitioners, scientists, regulators, and industry professionals.

More women are using marijuana during pregnancy in the U.S. and that might be causing health issues for their babies, two new studies suggest.

The CBD pet market is expected to reach $1.16 billion in the U.S. by 2022, according to the Brightfield Group.

In a study at the Hebrew University of Jerusalem, researchers found rodents treated with a cannabinoid derived from cannabis had significantly better recoveries.

Canada's largest pharmacy chain said Monday it is partnering with B.C.-based TruTrace to deploy a pilot program that uses blockchain to track strains and quality of medical marijuana.

A new study published this week contradicts previous findings that medical marijuana is an effective solution in preventing opioid-related deaths.

Research done by The Associated Press found that in many instances, the broader the state's legalization the more it cuts into medical marijuana programs.

According to patient groups, up to one million people will be eligible to use medical marijuana, a small fraction of the French population of nearly 70 million.

In the study published in The American Journal of Psychiatry, CBD oil was found effective in reducing both cue-induced cravings and anxiety in former heroin users.

Some of Canada's biggest cannabis players are already planting seeds to take advantage of what's expected to be a US$8.5 billion market by 2024, according to Prohibition Partners.

"It is incumbent on our lawmakers to provide physicians with opportunities to discuss alternatives to opioids and to provide patients with choices even if additional research regarding medical marijuana is necessary," Gov. Jared Polis said.

It is first cannabis company from Israel to apply to launch an initial public offering with the Toronto Stock Exchange.

Cannabis industry giant Canopy Growth Corp. (NYSE:CGC)(TSX:WEED) is partnering with drug awareness groups to create digital tools aimed to improve education and help youth, parents and teachers open up and talk about cannabis use.

The passed bill awaits governor approval and will broaden the range of health conditions medical cannabis can treat currently covered by state law.

Advancing study into the substance is “something that wouldn't be possible in the prohibition era,” said Rebecca Haines-Saah of the University of Calgary.

Despite encouraging results, researchers warned parents should wait for more data before they treat their children with autism.

Canopy Growth Corp (NYSE:CGC)(TSX:WEED) expands reach into Europe with a $342.9 million acquisition of medical cannabis company C3, based in Germany C3.

Green Relief Inc. could be an intriguing investment opportunity when it inevitably IPO's.